Related Experiment Videos
Apoptosis in Bowen's disease. An ultrastructural study.
M Kuligowski1, J H Dabrowski, S Jablonska
1Department of Dermatology, Warsaw Medical School, Poland.
The American Journal of Dermatopathology
|February 1, 1989
Summary
Apoptosis, or programmed cell death, was studied in Bowen's disease. The findings suggest that abundant apoptotic bodies may contribute to the slow, noninvasive growth characteristic of this skin cancer.
Area of Science:
- Dermatopathology
- Cell Biology
- Oncology
Background:
- Bowen's disease is a form of squamous cell carcinoma in situ.
- Apoptosis, a process of programmed cell death, plays a role in various diseases, including cancer.
- Human papillomavirus (HPV) has been implicated in some cases of Bowen's disease.
Purpose of the Study:
- To investigate the ultrastructural features of apoptosis in genital and cutaneous Bowen's disease.
- To compare the apoptotic process in HPV-associated and non-viral cutaneous lesions.
- To elucidate the potential role of apoptotic bodies in the clinical behavior of Bowen's disease.
Main Methods:
- Ultrastructural studies using electron microscopy were performed.
- Samples included one case of genital Bowen's carcinoma with HPV type 33 and two cases of cutaneous Bowen's disease without detectable viral DNA.
- Sequential stages of apoptotic body formation were documented.
Main Results:
- The apoptotic process observed in HPV-containing genital Bowen's disease was morphologically similar to that in cutaneous lesions lacking HPV.
- A significant number of apoptotic bodies were identified in both types of Bowen's disease.
- No distinct differences in apoptosis were noted between HPV-positive and HPV-negative cases.
Conclusions:
- The ultrastructural characteristics of apoptosis are consistent in HPV-associated and non-viral Bowen's disease.
- The high prevalence of apoptotic bodies in Bowen's disease may be a key factor in its characteristic slow progression and noninvasive growth.
- Further research into the role of apoptosis could offer insights into managing this carcinoma in situ.